|
|||||
|
|
| Pharmacist responsiveness and readiness for oral antivirals for COVID-19: A rebuttal to the AMA statement regarding the Biden administration’s test-to-treat plan | |
| 摘 要： | |
| 收稿时间： | 2022-03-07 |
| 本文献已被 ScienceDirect 等数据库收录！ | |
|
||||||||||
|
||||||||||
|
||||||||||
|
|
|
|
| 设为首页 | 免责声明 | 关于勤云 | 加入收藏 |
|
Copyright©北京勤云科技发展有限公司 京ICP备09084417号 |